NCT05398965 Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19) Status COMPLETED Phase PHASE2
NCT05398939 Impact of COVID-19 Vaccination on Serum 25-hydroxyvitamin D Level Status COMPLETED Phase N/A
NCT05398926 Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly Status COMPLETED Phase PHASE4
NCT05398848 Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov) Status COMPLETED Phase PHASE3
NCT05398718 Study on Sotrovimab and Its Impact on the Immune Response to COVID-19 Infection in Real-life in the UAE and Bahrain Status UNKNOWN Phase N/A
NCT05396573 A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19 Status UNKNOWN Phase PHASE1
NCT05394961 Factors Associated With Decisions to Withhold or Withdraw Intensive Care Status COMPLETED Phase N/A
NCT05394051 Psychological Well-being and Burnout in Healthcare Workers During the COVID-19 (Coronavirus Disease 2019) Pandemic Status COMPLETED Phase NA
NCT05394012 A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19 Status UNKNOWN Phase PHASE1
NCT05392088 Characterization and Prognostic Role of Myocardial Injury in Patients With COVID-19. The CardioCOVID Gemelli Study. Status RECRUITING Phase N/A
NCT05392075 COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose Status COMPLETED Phase N/A
NCT05389592 Treatment of COVID-19 Post-acute Cognitive Impairment Sequelae With tDCS Status COMPLETED Phase NA
NCT05389319 A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults Status RECRUITING Phase PHASE1
NCT05387655 Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05387395 COVID-19 on Disease Activity in Radiologically Isolated Syndrome Cohort Status COMPLETED Phase N/A
NCT05387369 A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19 Status RECRUITING Phase N/A